{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T06:15:26Z","timestamp":1782972926710,"version":"3.54.5"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.clinbiochem.2025.110941","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T13:08:48Z","timestamp":1746709728000},"page":"110941","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Shortcoming of serum B-cell maturation antigen measurement by enzyme-linked immunosorbent assay in one laboratory\u2019s experience: Unsatisfactory assay reproducibility"],"prefix":"10.1016","volume":"138","author":[{"given":"Ian","family":"Cheong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vipin","family":"Bhayana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Stevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Louzada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Chin-Yee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9106-316X","authenticated-orcid":false,"given":"Angela C.","family":"Rutledge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2025.110941_b0005","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.clinbiochem.2025.110941_b0010","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/0002-9343(78)90522-3","article-title":"Monoclonal gammopathy of undetermined significance, Natural history in 241 cases","volume":"64","author":"Kyle","year":"1978","journal-title":"Am. J. Med."},{"key":"10.1016\/j.clinbiochem.2025.110941_b0015","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","article-title":"Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: A report of the International Myeloma Working Group","volume":"121","author":"International Myeloma Working Group","year":"2003","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.clinbiochem.2025.110941_b0020","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3324\/haematol.2016.150896","article-title":"Serum B-cell maturation antigen: a novel biomarker to predict outcomes for multiple myeloma patients","volume":"102","author":"Ghermezi","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.clinbiochem.2025.110941_b0025","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/ajh.27225","article-title":"Soluble B-cell maturation antigen in multiple myeloma","volume":"99","author":"Costa","year":"2024","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.clinbiochem.2025.110941_b0030","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/10428194.2022.2133540","article-title":"The role of soluble B cell maturation antigen as a biomarker in multiple myeloma","volume":"64","author":"Alomari","year":"2023","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.clinbiochem.2025.110941_b0035","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/cei\/uxae043","article-title":"Elevated serum levels of soluble B-cell maturation antigen as a prognostic biomarker for multiple myeloma","volume":"217","author":"Guo","year":"2024","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clinbiochem.2025.110941_b0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1089\/adt.2020.1024","article-title":"A flexible multiplatform bioanalytical strategy for measurement of total circulating shed target receptors: application to soluble B cell maturation antigen levels in the presence of a bispecific antibody drug","volume":"19","author":"Stauffer","year":"2021","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.clinbiochem.2025.110941_b0045","article-title":"Serum soluble BCMA can be used to monitor relapse of multiple myeloma patients after chimeric antigen receptor T-cell immunotherapy","volume":"71","author":"Shen","year":"2023","journal-title":"Curr Res Transl Med."},{"key":"10.1016\/j.clinbiochem.2025.110941_b0050","doi-asserted-by":"crossref","DOI":"10.3389\/pore.2023.1611171","article-title":"Soluble B-cell maturation antigen as a monitoring marker for multiple myeloma","volume":"29","author":"Wiedemann","year":"2023","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.clinbiochem.2025.110941_b0055","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/bjh.16752","article-title":"Normalization of serum B-cell maturation antigen levels predicts overall survival among multiple myeloma patients starting treatment","volume":"192","author":"Jew","year":"2021","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.clinbiochem.2025.110941_b0060","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1365-2141.2012.09241.x","article-title":"Serum B-cell maturation antigen is elevated in multiple myeloma and correlates with disease status and survival","volume":"158","author":"Sanchez","year":"2012","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.clinbiochem.2025.110941_b0065","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/hon.2961","article-title":"Use of serum B-cell maturation antigen levels to predict outcomes for myeloma patients treated with ruxolitinib, lenalidomide, and methylprednisolone","volume":"40","author":"Bujarski","year":"2022","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.clinbiochem.2025.110941_b0070","first-page":"503","article-title":"Baseline and changes in serum B-cell maturation antigen levels rapidly indicate changes in clinical status among patients with relapsed\/refractory multiple myeloma starting new therapy, Target","volume":"16","author":"Bujarski","year":"2021","journal-title":"Oncol."},{"key":"10.1016\/j.clinbiochem.2025.110941_b0075","unstructured":"CLSI. User verification of precision and estimation of bias; Approved guideline 3rd edition. CLSI guideline EP15-A3. Clinical and Laboratory Standards Institute (2014)."},{"key":"10.1016\/j.clinbiochem.2025.110941_b0080","unstructured":"CLSI. Evaluation of linearity of quantitative measurement procedures; 2nd edition. CLSI guideline EP06. Clinical and Laboratory Standards Institute (2020)."},{"key":"10.1016\/j.clinbiochem.2025.110941_b0085","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1515\/cclm-2020-0061","article-title":"The CRESS checklist for reporting stability studies: on behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE)","volume":"59","author":"Cornes","year":"2021","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2025.110941_b0090","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.leukres.2019.04.008","article-title":"Serum B-cell maturation antigen (BCMA) reduces binding of anti-BCMA antibody to multiple myeloma cells","volume":"81","author":"Chen","year":"2019","journal-title":"Leuk. Res."},{"key":"10.1016\/j.clinbiochem.2025.110941_b0095","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s11523-019-00666-0","article-title":"Plasma B-cell maturation antigen levels are elevated and correlate with disease activity in patients with chronic lymphocytic leukemia","volume":"14","author":"Udd","year":"2019","journal-title":"Target Oncol."},{"key":"10.1016\/j.clinbiochem.2025.110941_b0100","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/bjh.16673","article-title":"Estimating a normal reference range for serum B-cell maturation antigen levels for multiple myeloma patients","volume":"192","author":"Jew","year":"2021","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.clinbiochem.2025.110941_b0105","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41408-021-00505-4","article-title":"Serum BCMA levels predict outcomes in MGUS and smoldering myeloma patients","volume":"11","author":"Visram","year":"2021","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.clinbiochem.2025.110941_b0110","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s11523-023-00990-6","article-title":"Clinical outcomes and serum B-cell maturation antigen levels in a real-world unselected population of newly-diagnosed multiple myeloma patients","volume":"18","author":"Jew","year":"2023","journal-title":"Target Oncol."},{"key":"10.1016\/j.clinbiochem.2025.110941_b0115","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.724411","article-title":"Study on the relationship between the expression of B cell mature antigen and the classification, stage, and prognostic factors of multiple myeloma","volume":"12","author":"Ma","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clinbiochem.2025.110941_b0120","doi-asserted-by":"crossref","first-page":"6599","DOI":"10.1182\/bloodadvances.2023010025","article-title":"Monoallelic deletion of BCMA is a frequent feature in multiple myeloma","volume":"7","author":"Samur","year":"2023","journal-title":"Blood Adv."},{"key":"10.1016\/j.clinbiochem.2025.110941_b0125","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1182\/blood.2023023557","article-title":"Antigen escape as a shared mechanism of resistance to BCMA-directed therapies in multiple myeloma","volume":"144","author":"Firestone","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.clinbiochem.2025.110941_b0130","doi-asserted-by":"crossref","first-page":"568","DOI":"10.3324\/haematol.2022.281339","article-title":"All-trans retinoic acid works synergistically with the gamma-secretase inhibitor crenigacestat to augment BCMA on multiple myeloma and the efficacy of BCMA-CAR T cells","volume":"108","author":"Garcia-Guerrero","year":"2023","journal-title":"Haematologica"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912025000700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912025000700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T08:14:53Z","timestamp":1752567293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912025000700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":26,"alternative-id":["S0009912025000700"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2025.110941","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Shortcoming of serum B-cell maturation antigen measurement by enzyme-linked immunosorbent assay in one laboratory\u2019s experience: Unsatisfactory assay reproducibility","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2025.110941","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110941"}}